FindTrial
Sign In

Multimarker in normal colorectal mucosa to predict occurrence of colorectal neoplasm

Multimarker in normal colon mucosa to predict occurrence of colorectal neoplasm

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000553
Enrollment
50
Registered
2012-10-09
Start date
2012-10-15
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who underwent colonoscopy at our institution during the study period

Exclusion criteria

Exclusion criteria: 1. Age 80 2. Familial adenomatous polyposis, Hereditary non-polyposis colorectal cancer 3. Inflammatory bowel disease 4. Prior history of previous colorectal resection 5. Coagulopathy (PT INR >1.5, platelet < 80,000/ml) 6. Anticoagulation therapy 7. Patients who can not discontinue antiplatelet agent(except aspirin) for 1 weeks before colonoscopy 8. Other severe diseases and acute disease (such as gastrointestinal bleeding, perforation or obstruction)

Design outcomes

Primary

MeasureTime frame
Association of Mulkimarker expression pattern and synchronous neoplasm—

Secondary

MeasureTime frame
Association of Mulkimarker expression pattern and metachronous neoplasm—

Countries

Korea, Republic of

Contacts

Public ContactHyo Jeong Lee

Asan Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026